Physiomics – “signs of returning to normality”, so why the share price fall?...
By Steve Moore | Monday 10 May 2021
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Physiomics (PYC) has updated including “we already see that clinical trials and patient recruitment are showing signs of returning to normality” and “the company’s cash position remains strong, and it is estimated that on 30 June 2021 its net asset position will be c.£1.1m, the majority of which is cash”. Why then have the shares currently responded to 5.95p, more than 7% lower?…
You must be a registered member to read this story
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.